Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
0.438
+0.018 (4.29%)
Nov 21, 2024, 2:45 PM EST - Market open

Company Description

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States.

The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.

It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.

The company sells it products through distribution partners, independent sales agents, and direct employees.

Catheter Precision, Inc. is based in Fort Mill, South Carolina.

Catheter Precision, Inc.
Catheter Precision logo
Country United States
Founded 2002
IPO Date Aug 30, 2018
Industry Medical Devices
Sector Healthcare
Employees 14
CEO David Jenkins

Contact Details

Address:
1670 Highway 160 West, Suite 205
Fort Mill, South Carolina 29708
United States
Phone 973-691-2000
Website catheterprecision.com

Stock Details

Ticker Symbol VTAK
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001716621
ISIN Number US74933X3026
Employer ID 38-3661826
SIC Code 3841

Key Executives

Name Position
David A. Jenkins Chief Executive Officer and Executive Chairman
Margrit Thomassen CPA Interim Chief Financial Officer and Secretary
Missiaen Huck Chief Operating Officer
Marie-Claude Jacques Chief Commercial Officer

Latest SEC Filings

Date Type Title
Nov 15, 2024 PRE 14A Other preliminary proxy statements
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 8-K Current Report
Nov 14, 2024 10-Q Quarterly Report
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 4, 2024 8-K/A [Amend] Current report
Oct 30, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Oct 30, 2024 8-K Current Report
Oct 25, 2024 424B3 Prospectus
Oct 25, 2024 8-K Current Report